NV-52

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameNV-52
Drug Alias NameNV-52NV-07β
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSuperoxide dismutase inhibitorsTumor necrosis factor α inhibitorsArachidonic acid inhibitors
TargetsArachidonic acidTumor necrosis factor αSuperoxide dismutase
Therapy Area/IndicationsCrohn DiseaseInflammatory Bowel DiseasesColitis, Ulcerative
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesKazia Therapeutics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKazia Therapeutics Ltd
Active IndicationsN/A
Inactive IndicationsCrohn DiseaseInflammatory Bowel DiseasesColitis, Ulcerative

Other Information

ATC CodeN/A
Related LinksN/A